PET Findings of Intramedullary Tumors of the Spinal Cord Using [18F] FDG and [11C] Methionine

BACKGROUND AND PURPOSE: Only a few reports on intramedullary tumors of the spinal cord using PET have been published. We report findings of PET by using [18F] fluorodeoxyglucose and [11C] methionine and discuss the usefulness of the findings in patients with intramedullary tumors of the spinal cord. MATERIALS AND METHODS: PET/CT was performed in 9 patients with intramedullary tumors of the spinal cord: Six had ependymomas, 1 had an anaplastic astrocytoma, 1 had a hemangioblastoma, and 1 had a cavernous angioma. The maximum standardized uptake value of the tumor was measured and compared with pathologic findings. RESULTS: The SUVmax of FDG and MET in a case of anaplastic astrocytoma was high. The SUVmax of FDG and MET was relatively high in 4 of 6 cases of ependymoma (excluding myxopapillary ependymomas). A case of hemangioblastoma showed decreased uptake of both FDG and MET (SUVmax = 2.0 and 1.4, respectively). Three cases with hemorrhage (1 case of ependymoma, 1 case of cellular ependymoma, and 1 case of cavernous angioma) showed a relatively increased uptake of FDG. CONCLUSIONS: Both FDG and MET accumulated to a large degree in an anaplastic astrocytoma and accumulated in ependymomas (excluding a myxopapillary ependymoma). FDG can accumulate in tumors with hemorrhage. More investigation of a larger number of patients is required to evaluate the diagnostic value of PET with FDG and MET for imaging intramedullary tumors of the spinal cord.

[1]  A. Grosu,et al.  11C-Methionine Positron Emission Tomography for Preoperative Evaluation of Suggestive Low-Grade Gliomas , 2007, Zentralblatt fur Neurochirurgie.

[2]  T. Cox,et al.  Positron Emission Tomography in Imaging Spinal Cord Tumors , 2000, Journal of child neurology.

[3]  Mark Muzi,et al.  Positron emission tomography imaging of brain tumors. , 2003, Neuroimaging clinics of North America.

[4]  Gabriele Stoffels,et al.  Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme. , 2011, International journal of radiation oncology, biology, physics.

[5]  J. Llamas-Elvira,et al.  The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer , 2010, Radiation oncology.

[6]  H. Klomp,et al.  Is 18F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer? , 2010, The Journal of Nuclear Medicine.

[7]  Karl Herholz,et al.  Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  W. Powers.  Intracerebral Hemorrhage and Head Trauma: Common Effects and Common Mechanisms of Injury , 2010, Stroke.

[9]  J. Alavi,et al.  Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Barry H. Smith,et al.  Metabolic Imaging of the Brain Stem and Spinal Cord: Studies with Positron Emission Tomography Using 18F‐2-Deoxyglucose in Normal and Pathological Cases , 1983, Journal of computer assisted tomography.

[11]  J. Thie.  Understanding the standardized uptake value, its methods, and implications for usage. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  V. Kapoor,et al.  An introduction to PET-CT imaging. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[13]  K. Hasuo,et al.  ¹¹C-choline and F-18 FDG PET/CT images of hemangioblastoma. , 2011, Clinical nuclear medicine.

[14]  J. Paeng,et al.  Evaluation of Focal Cortical Dysplasia and Mixed Neuronal and Glial Tumors in Pediatric Epilepsy Patients Using 18F-FDG and 11C-Methionine PET , 2010, Journal of Nuclear Medicine.

[15]  Y. Fujibayashi,et al.  Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET. , 2008, Nuclear medicine and biology.

[16]  C. Meltzer,et al.  FDG imaging of spinal cord primitive neuroectodermal tumor. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  P. Moreau,et al.  Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation? , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  W. Oyen,et al.  Imaging of infectious diseases using [18F] fluorodeoxyglucose PET. , 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[19]  N. Kawai,et al.  Comparison of 11C-Methionine PET and 18F-FDG PET in Patients with Primary Central Nervous System Lymphoma , 2011, Molecular Imaging and Biology.

[20]  J. Kestle,et al.  The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature. , 2005, Journal of neurosurgery.

[21]  K. Kang,et al.  Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI , 2010, Clinical Neurology and Neurosurgery.

[22]  Jae Seung Kim,et al.  [18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  Y. Guan,et al.  Comparison of MRI, F-18 FDG, and 11C-Choline PET/CT for Their Potentials in Differentiating Brain Tumor Recurrence From Brain Tumor Necrosis Following Radiotherapy , 2011, Clinical nuclear medicine.

[24]  S. Larson,et al.  18F-FDG PET/CT for the Prediction and Detection of Local Recurrence After Radiofrequency Ablation of Malignant Lung Lesions , 2010, The Journal of Nuclear Medicine.

[25]  Jan F. Jikeli,et al.  Analysis of the Growth Dynamics of Angiogenesis-Dependent and -Independent Experimental Glioblastomas by Multimodal Small-Animal PET and MRI , 2012, The Journal of Nuclear Medicine.

[26]  T. Videen,et al.  Transient focal increase in perihematomal glucose metabolism after acute human intracerebral hemorrhage. , 2009, Stroke.

[27]  M. Tripathi,et al.  UNUSUAL DIAGNOSIS OF VON HIPPEL LINDAU SYNDROME ON PET/CT – CASE REPORT AND BRIEF REVIEW OF LITERATURE , 2009 .

[28]  K. Schmiegelow,et al.  Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  F. Shishido,et al.  PET evaluation of spinal cord tumor using 11C-methionine. , 1990, Journal of computer assisted tomography.

[30]  T. Tamiya,et al.  Use of 11C-methionine positron emission tomography in basal germinoma: assessment of treatment response and residual tumor , 2009, Child's Nervous System.

[31]  A. Alavi,et al.  PET imaging for differentiating recurrent brain tumor from radiation necrosis. , 2005, Radiologic clinics of North America.

[32]  V. Ratanatharathorn,et al.  Relative roles of microsurgery and stereotactic radiosurgery for the treatment of patients with cranial meningiomas: a single-surgeon 4-year integrated experience with both modalities. , 2005, Journal of neurosurgery.

[33]  N. Saito,et al.  Primary spinal oligoastrocytoma: a case report. , 2004, Surgical neurology.

[34]  Y Muragaki,et al.  Analysis of 11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity , 2008, American Journal of Neuroradiology.

[35]  J. van den Hoff,et al.  Combined PET/MR systems: an overview and comparison of currently available options. , 2012, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[36]  J. Hatazawa,et al.  Spinal cord ependymoma: a positron emission tomographic study with (11C-methyl)-L-methionine , 2004, Neuroradiology.

[37]  Shigeaki Higashiyama,et al.  Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy , 2008, Journal of Nuclear Medicine.

[38]  N. Tamaki,et al.  Usefulness of 11C-Methionine for Differentiating Tumors from Granulomas in Experimental Rat Models: A Comparison with 18F-FDG and 18F-FLT , 2007, Journal of Nuclear Medicine.

[39]  Karl Herholz,et al.  18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.